Keyphrases
Patients with Cancer
100%
Transdermal Buprenorphine
100%
Opioid Agonist
100%
High Dose
100%
Buprenorphine
50%
Pain Relief
50%
Pain Intensity
50%
Cancer Patients
50%
Pharmacology
25%
Rescue Medication
25%
Pain Assessment
25%
Ceiling Effect
25%
Adverse Events
25%
Self-assessment
25%
Pain Interference
25%
Pain Episode
25%
Analgesic
25%
Quality of Life
25%
Breakthrough Pain
25%
Adverse Symptoms
25%
Switching Process
25%
Morphine
25%
Antagonist Activity
25%
Dose Conversion Factor
25%
Global Health Status
25%
Cancer Pain
25%
Brief Pain Inventory
25%
Moderate to Severe
25%
Stable Dose
25%
Medicine and Dentistry
Drug Megadose
100%
Buprenorphine
100%
Transdermal
100%
Analgesia
33%
Malignant Neoplasm
33%
Self-Diagnosis
16%
Quality of Life
16%
Health Status
16%
Side Effect
16%
Cancer Pain
16%
Adverse Event
16%
Brief Pain Inventory
16%
Breakthrough Pain
16%
Outpatient
16%
Morphine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Opiate Agonist
100%
Transdermal
100%
Malignant Neoplasm
100%
Buprenorphine
100%
Cancer Pain
16%
Health Status
16%
Morphine
16%
Side Effect
16%
Adverse Event
16%
Analgesic Agent
16%
Breakthrough Pain
16%